Richard Morphy,
Senior Research Advisor
After completing his Ph.D. at Durham University (U.K.) under the direction of Professor David Parker, Richard Morphy joined Celltech Ltd. in Slough (U.K.) as a medicinal chemist working on a variety of oncology and inflammation projects. Subsequently he moved to Organon Laboratories in Scotland where he was a section head in the medicinal chemistry department until 2011 through the mergers of Organon with Schering-Plough in 2007 and Merck in 2009. His focus there was on CNS disorders and he managed a number of collaborations with partners in Europe, the United States and Asia. Since last year, he has been working as a senior research advisor at the Lilly Research Centre at Windlesham, Surrey, UK.
|
|
|
